Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Langley

Showing results (21-30 of 333) with videos related to

Pageof 34
Sort By:
Clinical Therapeutics|January 7, 1998
Improving health care outcomes through reallocation of health care expendituresP C Langley
Innovations in Pharmacy|May 19, 2021
Tracking and Reporting Outcomes in Medical Marijuana: Establishing Condition Specific State Level RegistriesPaul C Langley
Innovations in Pharmacy|May 19, 2021
Another Rush to Judgment: The Imaginary Worlds of ICER and Recommendations in Duchenne Muscular DystrophyPaul C Langley
Innovations in Pharmacy|May 19, 2021
Yet another Ersatz World: The ICER Final Evidence Report for Additive Cardiovascular TherapiesPaul C Langley
Innovations in Pharmacy|May 19, 2021
The Great I-QALY DisasterPaul C Langley
Innovations in Pharmacy|May 19, 2021
Alternative Facts and the ICER Proposed Policy on Access to Imaginary Pharmacoeconomic WorldsPaul C Langley
Innovations in Pharmacy|August 29, 2022
A Critical Examination for the Pricing of Eculizumab and Efgartigimod in Myasthenia GravisPaul C Langley
Journal of Medical Economics|November 10, 2015
The status of modeled claimsPaul C Langley
Pharmacoeconomics|March 8, 1996
The November 1995 revised Australian guidelines for the economic evaluation of pharmaceuticalsP C Langley
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 15, 1995
Pharmacoeconomics and the quality of decision-making by pharmacy and therapeutics committeesP C Langley
Pageof 34

Showing results (21-30 of 333) with videos related to

Sort By:
Pageof 34
Clinical Therapeutics|January 7, 1998
Improving health care outcomes through reallocation of health care expendituresP C Langley
Innovations in Pharmacy|May 19, 2021
Tracking and Reporting Outcomes in Medical Marijuana: Establishing Condition Specific State Level RegistriesPaul C Langley
Innovations in Pharmacy|May 19, 2021
Another Rush to Judgment: The Imaginary Worlds of ICER and Recommendations in Duchenne Muscular DystrophyPaul C Langley
Innovations in Pharmacy|May 19, 2021
Yet another Ersatz World: The ICER Final Evidence Report for Additive Cardiovascular TherapiesPaul C Langley
Innovations in Pharmacy|May 19, 2021
The Great I-QALY DisasterPaul C Langley
Innovations in Pharmacy|May 19, 2021
Alternative Facts and the ICER Proposed Policy on Access to Imaginary Pharmacoeconomic WorldsPaul C Langley
Innovations in Pharmacy|August 29, 2022
A Critical Examination for the Pricing of Eculizumab and Efgartigimod in Myasthenia GravisPaul C Langley
Journal of Medical Economics|November 10, 2015
The status of modeled claimsPaul C Langley
Pharmacoeconomics|March 8, 1996
The November 1995 revised Australian guidelines for the economic evaluation of pharmaceuticalsP C Langley
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 15, 1995
Pharmacoeconomics and the quality of decision-making by pharmacy and therapeutics committeesP C Langley
Pageof 34